Compare XBIO & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XBIO | MLEC |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.7M |
| IPO Year | N/A | N/A |
| Metric | XBIO | MLEC |
|---|---|---|
| Price | $2.13 | $5.53 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.3K | ★ 894.7K |
| Earning Date | 03-17-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,858,935.00 | N/A |
| Revenue This Year | $1.99 | $20.42 |
| Revenue Next Year | $20.00 | $30.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 13.30 | ★ 170.36 |
| 52 Week Low | $1.90 | $3.08 |
| 52 Week High | $13.93 | $120.00 |
| Indicator | XBIO | MLEC |
|---|---|---|
| Relative Strength Index (RSI) | 40.19 | 54.43 |
| Support Level | $2.05 | $4.79 |
| Resistance Level | $2.69 | $5.89 |
| Average True Range (ATR) | 0.13 | 1.04 |
| MACD | -0.04 | -0.30 |
| Stochastic Oscillator | 6.76 | 22.74 |
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.